+ Filter

AGS-16

Anti-AGS-16 Products

Human Anti-AGS-16 Recombinant Antibody (TAB-027CL) (TAB-027CL)
- Species Reactivity: Human
- Type: Human IgG2, κ
- Application: ELISA
Compare

Afuco™ Anti-Human AGS-16 ADCC Recombinant Antibody (AGS-16M18), ADCC Enhanced (AFC-026CL)
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
Compare

Anti-AGS-16 (AGS-16M7.8)-Mc-MMAF ADC (AGS-16M8F) (ADC-L003)
- Target: AGS-16
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare

View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

Background

AGS-16 refers to an antigen that has been identified as a target for cancer therapies. In particular, it is related to targets found in renal cell carcinoma, liver carcinoma, and prostate cancer. The AGS-16 target is connected to the Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (ENPP3). This protein is found on the surface of cells, and is often over expressed on cancer cells. This trait, of over expression on cancer cells, allows it to be a target for monoclonal antibody treatments. There have been anticancer drugs created that target AGS-16. One example of this type of medicinal development is the "anti-AGS-16 monoclonal antibody AGS-16M18". Therefore AGS-16 represents a valuable target in the development of targeted cancer therapies.